Jane Street
AVIR icon

Jane Street’s Atea Pharmaceuticals AVIR Stock Holding History

Jane Street’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.25M Buy
418,296
+167,591
+67% +$770K ﹤0.01% 4862
2025
Q4 		$895K Buy
250,705
+58,611
+31% +$186K ﹤0.01% 6346
2025
Q3 		$557K Buy
192,094
+121,699
+173% +$416K ﹤0.01% 7619
2025
Q2 		$253K Sell
70,395
-32,212
-31% -$96.1K ﹤0.01% 8149
2025
Q1 		$307K Buy
102,607
+45,716
+80% +$143K ﹤0.01% 7765
2024
Q4 		$191K Sell
56,891
-35,394
-38% -$118K ﹤0.01% 8446
2024
Q3 		$309K Sell
92,285
-2,646
-3% -$9.59K ﹤0.01% 7980
2024
Q2 		$314K Buy
94,931
+50,382
+113% +$188K ﹤0.01% 7728
2024
Q1 		$180K Sell
44,549
-34,194
-43% -$134K ﹤0.01% 8246
2023
Q4 		$240K Buy
78,743
+63,935
+432% +$194K ﹤0.01% 7955
2023
Q3 		$44.4K Sell
14,808
-42,346
-74% -$144K ﹤0.01% 8177
2023
Q2 		$214K Sell
57,154
-60,442
-51% -$226K ﹤0.01% 7607
2023
Q1 		$394K Buy
117,596
+47,342
+67% +$192K ﹤0.01% 6739
2022
Q4 		$338K Buy
70,254
+45,934
+189% +$232K ﹤0.01% 6807
2022
Q3 		$138K Buy
24,320
+5,348
+28% +$40.9K ﹤0.01% 8456
2022
Q2 		$135K Sell
18,972
-94,057
-83% -$642K ﹤0.01% 8482
2022
Q1 		$816K Sell
113,029
-133,887
-54% -$909K ﹤0.01% 6544
2021
Q4 		$2.21M Buy
246,916
+172,550
+232% +$2.69M ﹤0.01% 4282
2021
Q3 		$2.61M Buy
74,366
+59,011
+384% +$1.64M ﹤0.01% 3938
2021
Q2 		$330K Buy
+15,355
New +$461K ﹤0.01% 7980

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Jane Street's AVIR Position: Q1 2026 in Review

Jane Street increased its Atea Pharmaceuticals (AVIR) stake by 67% in Q1 2026, buying an estimated $770K and bringing the position to 418,296 shares worth $2.25M. The position accounts for ﹤0.01% of the portfolio, ranked #4862.

Jane Street first reported a position in AVIR in Q2 2021 and has held it in 20 quarters since. The position peaked at $2.61M in Q3 2021. 127 funds tracked by Wall St. Rank hold AVIR as of Q1 2026.

  • Jane Street held 418,296 shares of Atea Pharmaceuticals worth $2.25M as of Q1 2026.
  • Jane Street bought 167,591 Atea Pharmaceuticals shares in Q1 2026, an estimated $770K.
  • Atea Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #4862 holding.
  • Jane Street first reported a position in Atea Pharmaceuticals in Q2 2021 and has held it in 20 quarters since.
  • Jane Street's Atea Pharmaceuticals position peaked at $2.61M in Q3 2021.
  • 127 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.